Achieve Life Sciences (ACHV) has just received a rare Commissioner's National Priority Voucher from the FDA for its cytisinicline therapy targeting nicotine dependence in e-vaping. This move could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback